Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Salim S. Hayek, Evangelos J. Giamarellos‐Bourboulis et al.|Diabetes Care|2022Cited by 74
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19Alexi Vasbinder, Tariq U. Azam, Rodica Pop‐Busui et al.|Circulation Cardiovascular Quality and Outcomes|2022Cited by 34
Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19Michael Pan, Hanna Berlin, Pennelope Blakely et al.|Journal of the American Heart Association|2021Cited by 29
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19Shengyuan Luo, Yiyuan Huang, Kim A. Williams et al.|Journal of the American Heart Association|2022Cited by 16
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19Alexi Vasbinder, Evangelos J. Giamarellos‐Bourboulis, Tariq U. Azam et al.|Journal of Medical Virology|2024Cited by 14